Saudi Arabia Buccal Drug Delivery Systems Market Size & Outlook

The buccal drug delivery systems market in Saudi Arabia is expected to reach a projected revenue of US$ 119.1 million by 2028. A compound annual growth rate of 7.3% is expected of Saudi Arabia buccal drug delivery systems market from 2022 to 2028.
Revenue, 2021 (US$M)
$72.7
Forecast, 2028 (US$M)
$119.1
CAGR, 2022 - 2028
7.3%
Report Coverage
Saudi Arabia

To keep accessing Horizon, please sign in or register for a free account

  • Access to global market statistics
  • Access to company profiles
  • Free use-cases & research insights

No credit card required*

Saudi Arabia buccal drug delivery systems market, 2016-2028 (US$M)

Saudi Arabia buccal drug delivery systems market, 2016-2028 (US$M)

To keep accessing Horizon, please sign in or register for a free account

  • Access to global market statistics
  • Access to company profiles
  • Free use-cases & research insights

No credit card required*

Saudi Arabia buccal drug delivery systems market highlights

  • The Saudi Arabia buccal drug delivery systems market generated a revenue of USD 72.7 million in 2021 and is expected to reach USD 119.1 million by 2028.
  • The Saudi Arabia market is expected to grow at a CAGR of 7.3% from 2022 to 2028.
  • In terms of segment, buccal tablets/ lozenges was the largest revenue generating type in 2021.
  • Sublingual Films And Wafers is the most lucrative type segment registering the fastest growth during the forecast period.


Buccal drug delivery systems market data book summary

Market revenue in 2021USD 72.7 million
Market revenue in 2028USD 119.1 million
Growth rate7.3% (CAGR from 2021 to 2028)
Largest segmentBuccal tablets/ lozenges
Fastest growing segmentSublingual Films And Wafers
Historical data2016 - 2020
Base year2021
Forecast period2022 - 2028
Quantitative unitsRevenue in USD million
Market segmentationSublingual Films And Wafers, Buccal Tablets/ Lozenges, Oral Sprays
Key market players worldwideTeva Pharmaceutical Industries Ltd, Pfizer Inc, Reckitt Benckiser Group PLC, Catalent Inc, Collegium Pharmaceutical Inc, Cynata Therapeutics Ltd, GlaxoSmithKline Consumer Healthcare (GSK CH India), Generex Biotechnology, ARx, Endo Pharmaceuticals


Other key industry trends

  • In terms of revenue, Saudi Arabia accounted for 2.3% of the global buccal drug delivery systems market in 2021.
  • Country-wise, U.S. is expected to lead the global market in terms of revenue in 2028.
  • In Middle East & Africa, South Africa buccal drug delivery systems market is projected to lead the regional market in terms of revenue in 2028.
  • South Africa is the fastest growing regional market in Middle East & Africa and is projected to reach USD 128.5 million by 2028.

No credit card required*

Horizon in a snapshot

  • 30K+ Global Market Reports
  • 120K+ Country Reports
  • 1.2M+ Market Statistics
  • 200K+ Company Profiles
  • Industry insights and more

Buccal Drug Delivery Systems Market Companies

Name Profile # Employees HQ Website
ARx View profile 51-100 Glen Rock, Pennsylvania, United States, North America https://arxpharma.com/
Generex Biotechnology View profile 51-100 Miramar Beach, Florida, United States, North America http://www.generex.com
GlaxoSmithKline Consumer Healthcare (GSK CH India) View profile 1001-5000 Gurgaon, Haryana, India, Asia https://india-consumer.gsk.com/
Endo Pharmaceuticals View profile 1001-5000 Ballsbridge, Dublin, Ireland, Europe http://www.endo.com
Cynata Therapeutics Ltd View profile 2 100 Cubitt Street, Level 3, Cremorne, VIC, Australia, 3121 https://www.cynata.com
Collegium Pharmaceutical Inc View profile 197 100 Technology Center Drive, Stoughton, MA, United States, 02072 https://www.collegiumpharma.com
Catalent Inc View profile 17219 14 Schoolhouse Road, Somerset, NJ, United States, 08873 https://www.catalent.com
Reckitt Benckiser Group PLC View profile 40000 103-105 Bath Road, Slough, Berkshire, United Kingdom, SL1 3UH https://www.reckitt.com
Pfizer Inc View profile 88000 66 Hudson Boulevard East, New York, NY, United States, 10001-2192 https://www.pfizer.com
Teva Pharmaceutical Industries Ltd View profile 37851 124 Dvora HaNevi’a Street, Tel Aviv, Israel, 6944020 https://www.tevapharm.com

Saudi Arabia buccal drug delivery systems market outlook

The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to buccal drug delivery systems market will help companies and investors design strategic landscapes.


Buccal tablets/ lozenges was the largest segment with a revenue share of 49.11% in 2021. Horizon Databook has segmented the Saudi Arabia buccal drug delivery systems market based on sublingual films and wafers, buccal tablets/ lozenges, oral sprays covering the revenue growth of each sub-segment from 2016 to 2028.


Reasons to subscribe to Saudi Arabia buccal drug delivery systems market databook:

  • Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
  • Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
  • Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
  • Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
  • Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.

Target buyers of Saudi Arabia buccal drug delivery systems market databook

  • Our clientele includes a mix of buccal drug delivery systems market companies, investment firms, advisory firms & academic institutions.
  • 30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
  • Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
  • The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.

Horizon Databook provides a detailed overview of country-level data and insights on the Saudi Arabia buccal drug delivery systems market , including forecasts for subscribers. This country databook contains high-level insights into Saudi Arabia buccal drug delivery systems market from 2016 to 2028, including revenue numbers, major trends, and company profiles.

Partial client list

  • logo

Saudi Arabia buccal drug delivery systems market size, by type, 2016-2028 (US$M)

Saudi Arabia Buccal Drug Delivery Systems Market Outlook Share, 2021 & 2028 (US$M)

Saudi Arabia buccal drug delivery systems market size, by type, 2016-2028 (US$M)

Sign up - it's easy, and free!

Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our free plan indefinitely.

Explore all plans

Included in Horizon account

  • 30K+ Global Market Reports
  • 120K+ Country Reports
  • 1.2M+ Market Statistics
  • 200K+ Company Profiles
  • Industry insights and more
Chat with us
Research Assistance
Online